Former NFL pro Chris Maragos wins $43.5 million medical malpractice claim

Published Date: 02 Mar 2023

The legal team said the jury's decision could make medics think twice before allowing the injured to return to the field.

Read Full News

Latest News

AI Tool Offers Early Warning System for Drug Shortages

A new platform developed by researchers at the University of Toronto uses real-world data and AI-enabled forecasting to identify medications that may soon be in short supply.

Amplify, Apply, Advance: Bridging Academic Expertise and Community Practice to Elevate CML Care

Amplify, Apply, Advance: Bridging Academic Expertise and Community Practice to Elevate CML Care

Brain Changes Linked With Speech-in-Noise Impairment

Aspects of the "cocktail party effect" may emerge before cognitive decline is detected

No Survival Dip After Skipping Axillary Surgery for Some Early Breast Cancers

Applies to most patients with one or two positive sentinel lymph nodes

No Difference in Complications for Chiari I Surgical Approaches in Kids, Study Shows

Cluster-randomized controlled trial examined decompression with and without duraplasty

Senators Clash Over Youth Gender Care Bans

Hearing comes amid the Trump administration's targeting of care

Todays Updates

Buprenorphine XR Injections Cut 'Need-Based' Opioid Craving

Extended-release buprenorphine injections increase the number of opioid-free days primarily via direct pathways and by suppressing need-related craving, a causal mediation analysis shows.

Fatty Pancreas Linked to Risk for T2D and CKD

Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.

Todays Updates

Buprenorphine XR Injections Cut 'Need-Based' Opioid Craving

Extended-release buprenorphine injections increase the number of opioid-free days primarily via direct pathways and by suppressing need-related craving, a causal mediation analysis shows.

Fatty Pancreas Linked to Risk for T2D and CKD

Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.

Latest News

A new platform developed by researchers at the University of Toronto uses real-world data and AI-enabled forecasting to identify medications that may soon be in short supply.

Amplify, Apply, Advance: Bridging Academic Expertise and Community Practice to Elevate CML Care

Aspects of the "cocktail party effect" may emerge before cognitive decline is detected

Applies to most patients with one or two positive sentinel lymph nodes

Cluster-randomized controlled trial examined decompression with and without duraplasty

Hearing comes amid the Trump administration's targeting of care

News All Time

Patient Requests That Can Put You In a Tough Position

Requests for emotional support animals, disabled parking placards, and, more recently, Medicaid work exemptions can prove challenging for physicians. Here’s what you need to know.

Europe’s Medical Loophole for Banned Doctors

A doctor struck off in France kept practicing in Belgium, exposing how gaps in EU medical oversight can let sanctioned clinicians cross borders.

Rare Adenoid Cystic Breast Cancer in a Woman

A woman with rare breast adenoid cystic carcinoma carries a BRIP1 variant of uncertain significance, highlighting the challenges in genetic risk assessment.

What the FDA's Hormone Therapy Decision Means for Aging Skin

Skin collagen content decreases at a rate of approximately 1%-2% per year in the early postmenopausal period, skin thickness diminishes, barrier function weakens, and moisture retention falters

US FDA Approves Pfizer's Bleeding Disorder Drug for Children

(Corrects paragraph 2 to say Hympavzi is the first non-factor therapy particularly for pediatric patients with hemophilia ⁠B, not all)

Ask the HF Expert: Advanced Therapies

Dr Yash Varma, a chief cardiology fellow, asks Dr Ileana Piña for her insights on when a patient with heart failure should be referred for advanced therapies.

Selpercatinib Cuts Recurrence Risk in Early RET+ NSCLC

In the first phase 3 trial of a RET inhibitor as adjuvant therapy, selpercatinib markedly improved event-free survival vs placebo in early-stage RET fusion-positive NSCLC.

More Women With Breast Cancer Can Skip Axillary Dissection

The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection.

Tile-Based Radiation to Treat Large Brain Metastases?

The GammaTile may improve outcomes over standard stereotactic RT after resection of large brain metastases, but a striking overall survival benefit in a phase 3 trial raises questions.

Will PROTEUS Change the Playbook for Radical Prostatectomy?

New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy.

S1 Episode 4: Managing Heart Failure in ATTR-CM

From narrow volume windows to SGLT2 inhibitors and emerging devices, Drs Kevin Alexander and Sarah Cuddy discuss heart failure care in ATTR-CM.

Coconut Oil

Current evidence supports the use of this botanical agent to promote skin health, but more research is needed to ascertain more varied and curative applications for this popular natural product.

Micrometer CT Reveals Clitoral Neural Anatomy

High resolution 3-D imaging reveals a dense, branching dorsal nerve network in the clitoral glans, challenging anatomical assumptions and guiding surgical strategies to preserve sensation.

May 22 2026 This Week in Cardiology

Three more digoxin trials, yet another GLP-1 drug on the horizon, vagal nerve stimulation, trial inside baseball, and more on lipid guidelines are the topics John Mandrola, MD, discusses in this week’s podcast.

Does Surgery Type Matter for Young Women With High-Risk BC?

Younger women with high-risk breast cancer often opt for mastectomy, but it may not improve survival or reduce recurrences versus breast-conserving surgery.

Ask the HF Expert: Guideline-Directed Medical Therapy

Chief Cardiology fellow Yash Varma asks HF expert Ileana Piña for tips on when patients are stable to discharge on guideline-directed medical therapy and if it’s ever ok to de-escalate.

Recommended News For You

In cancer survivors, loneliness is associated with a higher risk of death.

Telemedicine services linked to reducing excess mortality

Tumor characteristics found to differ for melanomas in children, teens and young adults

Patients face high out-of-pocket costs after incident cancer diagnosis

Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions

A Win for Molecularly Guided Therapy for Cancer of Unknown Primary

Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.

Recommended Articles For You

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide 

Colon cancer: Risk factors, warning signs and treatment options  

Multiple Primary Lung Cancer: Multidisciplinary Advances in Diagnosis and Care 

The Truth About Marijuana and Its Effect on Mental Health  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Analysis of NRG trial in limited-stage small cell lung cancer suggests QOL benefit with twice- vs. once-daily radiation

2.

a brand-new generic therapy for different types of cancer.

3.

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.

4.

Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.

5.

ALK Inhibitor Shows Promise in Rare, Progressive Tumor Types

1.

Beyond Symptoms: The Predictive Promise of Targeted Radionuclide Therapy in Palliative Oncology

2.

Botulinum Toxins in Oncology: A New Frontier in Chronic Pain Management and Apoptosis Induction

3.

How is Digital Innovation Revolutionizing Gynecologic Oncology Treatment and Patient Engagement?

4.

ctDNA in Oncology: Transforming MRD Assessment, Disease Tracking, and Early Cancer Detection

5.

Leptomeningeal Carcinomatosis: Symptoms, Causes, and Treatment Options

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

3.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

4.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot